Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guixian Wu

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Biomed Research International|April 30, 2021
Prognostic Significance of CD56 Antigen Expression in Patients with <i>De Novo</i> Non-M3 Acute Myeloid LeukemiaYanni Sun, Jia Wan, Qiuyue Song, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2026
Anlotinib + Toripalimab maintenance in Extensive-Stage small cell lung Cancer: Clinical efficacy and preclinical mechanism of anlotinib-induced neuroendocrine differentiation Suppression via Notch1Dongqing Lv, Ruiqing Zhu, Guixian Wu, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Biomed Research International|April 30, 2021
Prognostic Significance of CD56 Antigen Expression in Patients with <i>De Novo</i> Non-M3 Acute Myeloid LeukemiaYanni Sun, Jia Wan, Qiuyue Song, et al.
Lung Cancer (Amsterdam, Netherlands)|March 13, 2026
Anlotinib + Toripalimab maintenance in Extensive-Stage small cell lung Cancer: Clinical efficacy and preclinical mechanism of anlotinib-induced neuroendocrine differentiation Suppression via Notch1Dongqing Lv, Ruiqing Zhu, Guixian Wu, et al.
Pageof 5